Another investigation revealed that a ruthenium-based radiosensitizer, combined with 111In-labeled polymeric nanoparticles, may induce combinational and targeted therapeutic effects on cancer cells overexpressing the human epidermal growth factor receptor (EGFR) (33, 34). Here, EGFR is linked to cancer.